MURALI RAMACHANDRAN (VP of Research and Development) purchased 0.2% of their position (200.00 shares) of KAIROS PHARMA, LTD. on the open market
Open‑market purchase worth $318.00 — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/25/2024ACC: 0001493152-24-047695
Officer· VP of Research and Development
Since Sep 2024
+200.00
Net shares
Net buyer
$318.00
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
200.00 acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+200.00
Price / share
$1.59
Trade value
$318.00
% of position
0.2%
11/25/2024
132.86K→133.06K
Total
Net shares
+200.00
Net value
$318.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 11/25/2024 | P · Purchase | +200.00 | $1.59 | $318.00 | 0.2% | 132.86K | 133.06K |
| Total | +200.00 | $318.00 | ||||||
Derivative Transactions0
No derivative transactions reported